國立虎尾科技大學 |

Breast Cancer: From Bench to Personalized Medicine

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Breast Cancer: From Bench to Personalized Medicine/ edited by Saima Shakil Malik, Nosheen Masood.
other author:	Shakil Malik, Saima.
Description:	XVII, 536 p. 1 illus.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cancer. -
Online resource:	https://doi.org/10.1007/978-981-19-0197-3
ISBN:	9789811901973

Breast Cancer: From Bench to Personalized Medicine
Breast Cancer: From Bench to Personalized Medicine[electronic resource] /edited by Saima Shakil Malik, Nosheen Masood. - 1st ed. 2022. - XVII, 536 p. 1 illus.online resource.

Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.

This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.

ISBN: 9789811901973

Standard No.: 10.1007/978-981-19-0197-3doiSubjects--Topical Terms:

581034
Cancer.

LC Class. No.: RC261-271

Dewey Class. No.: 571.978

Breast Cancer: From Bench to Personalized Medicine
LDR:02814nam a22004095i 4500 001 1088878
003 DE-He213
005 20220514091817.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811901973 $9 978-981-19-0197-3
024 7 $a 10.1007/978-981-19-0197-3 $2 doi
035 $a 978-981-19-0197-3
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 571.978 $2 23
082 0 4 $a 616.994 $2 23
245 1 0 $a Breast Cancer: From Bench to Personalized Medicine $h [electronic resource] / $c edited by Saima Shakil Malik, Nosheen Masood.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a XVII, 536 p. 1 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.
520 $a This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.
650 0 $a Cancer. $3 581034
650 0 $a Cancer—Epidemiology. $3 1396097
650 0 $a Cancer—Genetic aspects. $3 1391073
650 1 4 $a Cancer Biology. $3 1388882
650 2 4 $a Cancer Epidemiology. $3 1396098
650 2 4 $a Cancer Genetics and Genomics. $3 1391074
700 1 $a Shakil Malik, Saima. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1318982
700 1 $a Masood, Nosheen. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1318981
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811901966
776 0 8 $i Printed edition: $z 9789811901980
776 0 8 $i Printed edition: $z 9789811901997
856 4 0 $u https://doi.org/10.1007/978-981-19-0197-3
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)